Regulus Therapeutics Inc. RGLS

RGLS

Regulus Therapeutics Inc.

Exchange: nyse

Multiples

P/E: -1.64
P/BV: 0.78
P/TBV: 3.21

Description:

none

Data:

Market Cap

68093904.00

EBITDA

Net Income

Yields:

Earnings Yield

Return on Capital

CAGR (net income)

0%

CAGR Length

0

Dividend Rate